G&S Capital LLC Alaunos Therapeutics, Inc. Transaction History

G&S Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$3.95 - $5.35 $17,775 - $24,075	-4,500 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$3.98 - $6.2 $3,980 - $6,200	-1,000 Reduced 18.18%	4,500 $26,000
Q1 2019 Apr 22, 2019	SELL	$2.0 - $4.4 $25,000 - $55,000	-12,500 Reduced 69.44%	5,500 $21,000
Q4 2018 Jan 15, 2019	SELL	$1.61 - $3.62 $19,803 - $44,526	-12,300 Reduced 40.59%	18,000 $34,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $121,200 - $198,162	30,300	30,300 $125,000

106K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $141M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.